THG
THG · Main Market · Personal Care, Drug and Grocery Stores · mcap £416m · 27.2p
THG owns online beauty retailers such as LOOKFANTASTIC and sports nutrition brand Myprotein. Until January 2025 it also ran Ingenuity, a platform that sells ecommerce services to other brands.
| Target | Promise | Said | Status |
|---|---|---|---|
| 2024 | |||
| FY 2024 | FY 2024 capex of £100m-£110m | 17 Oct 2023 | ✗ Missed · target changed |
|
“we now anticipate FY 2024 capex spend will be c.£30m less than previously guided at £100m to £110m”
Also stated 16 Jan 2024 · 10 Apr 2024
Result
After the demerger, capex was reset to about £20m a year for RemainCo. “Specifically, capital expenditure will reduce to c. £20m pa (FY 2024 pre Demerger guidance: £100m to £110m)”23 Jan 2025 · Q4 2024 Trading Statement |
|||
| FY 2024 | All divisions to deliver growth in FY 2024 | 16 Jan 2024 | ✗ Missed |
|
Result
Nutrition revenue fell in 2024, from £658m to £580m. “THG Nutrition | 145.2 | -9.5% | -12.7% | 579.6 | -8.7% | -11.9%”23 Jan 2025 · Q4 2024 Trading Statement “A standout performance from THG Beauty (+4.6%), with broad and consistent gains across skin, cosmetics and fragrance categories in the UK, offsetting a transitional year for THG Nutrition where promotional activity in support of the rebrand was elevated to clear old brand stock.”23 Jan 2025 · Q4 2024 Trading Statement |
|||
| H2 2024 | Launch local manufacturing in Japan and India in H2 2024 | 16 Jan 2024 | … In progress |
|
Also stated 10 Apr 2024
Status so far
Not yet due. |
|||
| H2 2024 | H1 2024 revenue growth of 2-5%, moving to high single digits in H2 | 23 Apr 2024 | ◐ Partly kept |
|
Status so far
H1 2024 grew 2.2%, in range. Q3 fell 0.6%, so H2 did not reach high single digits. “Continuing Q3 revenue of £433.1m (-0.6% CCY)”10 Oct 2024 · Q3 2024 Trading Statement |
|||
| Q3 2024 | Nutrition to exit Q3 2024 in revenue growth | 17 Sep 2024 | ✗ Missed |
|
Result
Q3 2024 Nutrition revenue fell 10.5% at constant currency. “THG Nutrition | 134.5 | -13.1% | -10.5%”10 Oct 2024 · Q3 2024 Trading Statement “Nutrition YoY revenue performance improved each month through the quarter.”10 Oct 2024 · Q3 2024 Trading Statement |
|||
| End 2024 | Year-end 2024 net debt broadly unchanged year on year | 17 Sep 2024 | ✓ Kept |
|
Result
Net debt was £215m versus £218m a year earlier. 29 Apr 2025 · FY 2024 results and Q1 trading statement |
|||
| 2025 | |||
| 2 Jan 2025 | Demerge Ingenuity by 2 January 2025 | 17 Sep 2024 | ✓ Kept |
|
Also stated 17 Dec 2024
|
|||
| FY 2025 | Nutrition adjusted EBITDA margin back to about 12% in FY 2025 | 17 Sep 2024 | … In progress |
|
Status so far
Not yet due. |
|||
| 2025-03 | Transfer to ESCC listing category by March 2025, then FTSE index inclusion | 17 Sep 2024 | ✓ Kept |
|
Also stated 10 Oct 2024
Result
Transfer took effect 6 January 2025. FTSE 250 inclusion followed around 21 March 2025. “The Transfer became effective at 8.00 a.m. today, 6 January 2025.”6 Jan 2025 · Transfer to ESCC Category “Subject to confirmation from FTSE Russell, FTSE 250 index inclusion is expected to become effective on or around 21 March 2025.”6 Mar 2025 · Inclusion in FTSE 250 Index |
|||
| FY 2025 | Mid-single digit revenue growth in FY 2025 | 23 Jan 2025 | ◐ Partly kept |
|
Also stated 29 Apr 2025
Status so far
FY 2025 revenue grew 2.3% at constant currency, below mid-single digit, though H2 grew 6.7%. “The Group delivered adjusted revenue of £1,717.0m (+2.3% continuing CCY).”26 Mar 2026 · Preliminary FY 2025 results |
|||
| FY 2025 | Myprotein offline and licensed retail sales of about £170m in FY 2025 | 25 Jun 2025 | … In progress |
|
“The retail sales value of offline and licensed products is expected to be around £170m for FY 2025”
Status so far
Not yet due. |
|||
| H2 2025 | Nutrition H2 2025 revenue growth of 10-12% | 6 Aug 2025 | ◐ Partly kept |
|
Also stated 11 Sep 2025
Status so far
Nutrition grew 10.0% in Q3 and 8.5% in Q4, about 9.7% for H2, just under the range. “THG Nutrition delivered +9.2% H2 revenue growth (+12.7% excluding Asia), broadly in-line with the +10.0% to +12.0% guidance.”13 Jan 2026 · Q4 2025 Trading Statement |
|||
| H2 2025 | Group adjusted EBITDA of about £50m in H2 2025 | 6 Aug 2025 | ✓ Kept |
|
Result
FY 2025 EBITDA of £76.6m less H1's £24m gives about £53m. “FY 2025 Adjusted EBITDA of £76.6m (FY 2024: £83.3m): ahead of guidance (c.£74m) and company consensus”26 Mar 2026 · Preliminary FY 2025 results |
|||
| H2 2025 | Beauty H2 2025 revenue growth of 1-3% | 11 Sep 2025 | ✓ Kept |
|
Result
Beauty grew 4.2% in Q3 and 6.4% in Q4, above the range. “THG Beauty delivered +5.5% H2 revenue growth, well ahead of +1.0% to +3.0% guidance”13 Jan 2026 · Q4 2025 Trading Statement |
|||
| FY 2025 | FY 2025 performance in line with consensus | 14 Oct 2025 | ✓ Kept |
|
Result
FY 2025 adjusted EBITDA of £76.6m was ahead of guidance. “FY 2025 Adjusted EBITDA of £76.6m (FY 2024: £83.3m): ahead of guidance (c.£74m) and company consensus”26 Mar 2026 · Preliminary FY 2025 results |
|||
| 31 Dec 2025 | Sell 45m Myprotein units through over 40,000 doors by end-2025 | 17 Nov 2025 | ◐ Partly kept |
|
Result
Over 43m licensed units were sold in 2025, just short of 45m. Door count not confirmed. “Licensing agreements with category leaders including Müller, Iceland and Jimmy's Coffee, led to sales of over 43 million Myprotein units into retail during 2025.”12 Feb 2026 · Myprotein licensing partnership with Greencore |
|||
| Today · 10 Oct 2026 | |||
| 2026 | |||
| FY 2026 | Sell in over 60m licensed products in FY 2026 | 12 Feb 2026 | … In progress |
|
Also stated 24 Jun 2026
Status so far
Not yet due. |
|||
| FY 2026 | Net debt of £110m-£130m by end FY 2026 | 26 Mar 2026 | … In progress |
|
Status so far
Not yet due. |
|||
| FY 2026 | FY 2026 free cash flow of £25m-£35m | 26 Mar 2026 | ✗ Missed · target changed |
|
Also stated 21 Apr 2026 · 10 Sep 2026
Result
Range narrowed from £25m-£50m to £25m-£35m in September 2026, lowering the top end. “The Group remains focused on generating significant positive free cash flow and is on target to deliver £25m to £35m positive free cash flow for FY 2026, in line with consensus”10 Sep 2026 · Half-year Results |
|||
| FY 2026 | Nutrition mid-to-high single digit growth in FY 2026 | 26 Mar 2026 | … In progress |
|
Status so far
Not yet due. |
|||
| H2 2026 | Myprotein to enter energy, protein water and breakfast categories in H2 2026 | 24 Jun 2026 | … In progress |
|
Status so far
Not yet due. |
|||
| FY 2026 | Sell over 130m Myprotein units in FY 2026 | 10 Sep 2026 | … In progress |
|
Status so far
Not yet due. |
|||
| 2027 | |||
| H1 2027 | Complete Asia retail move from direct sales to licensing in H1 2027 | 10 Sep 2026 | … In progress |
|
Status so far
Not yet due. |
|||